FIELD: pharmacology.
SUBSTANCE: invention relates to a method for introduction of a polypeptide comprising an epidermal growth factor (EGF-like) domain to a mammal, the said method comprising: polypeptide introduction after neurologic damage in the said mammal; and beginning of introduction within a subacute window after neurological damage.
EFFECT: effective introduction of this factor to limit brain damage, restore functions and/or enhance recovery after neurological damage.
10 cl, 19 ex, 4 tbl, 18 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR TREATING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL DAMAGE | 2009 |
|
RU2501564C2 |
| THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE | 2014 |
|
RU2698090C2 |
| APPLICATION OF PEPTIDE GGF2 IN TREATMENT OR PREVENTION OF HEART FAILURE IN MAMMALS | 2009 |
|
RU2536938C2 |
| METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS | 2014 |
|
RU2687097C2 |
| METHOD OF PROVIDING REQUIRED LEVELS OF GLIAL GROWTH FACTOR 2 IN PLASMA | 2009 |
|
RU2530650C2 |
| THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE | 2019 |
|
RU2719199C1 |
| ACTIVE SOLUBLE ISOFORMS OF NEUREGULIN, WHICH CARRY POST-TRANSLATION MODIFICATIONS | 2008 |
|
RU2491955C2 |
| PHARMACEUTICAL COMBINATION INCLUDING EPIDERMAL GROWTH FACTOR AND GHRP6 PEPTIDE AS A SECRETION STIMULATOR FOR RECOVERY AFTER BRAIN DAMAGE | 2019 |
|
RU2776812C1 |
| METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS | 2003 |
|
RU2353385C2 |
| METHODS FOR DETECTING CARDIAC DISORDERS | 2008 |
|
RU2498309C2 |
